RIGHI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 3.765
AS - Asia 3.650
EU - Europa 2.511
AF - Africa 232
SA - Sud America 184
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.354
Nazione #
US - Stati Uniti d'America 3.703
CN - Cina 1.002
VN - Vietnam 972
SG - Singapore 956
GB - Regno Unito 603
IT - Italia 391
DE - Germania 315
SE - Svezia 311
HK - Hong Kong 202
IN - India 195
FR - Francia 168
BR - Brasile 131
RU - Federazione Russa 131
UA - Ucraina 111
IE - Irlanda 100
NL - Olanda 86
ZA - Sudafrica 66
CI - Costa d'Avorio 63
FI - Finlandia 57
JP - Giappone 57
CH - Svizzera 55
KR - Corea 55
TG - Togo 49
EE - Estonia 38
CA - Canada 37
BG - Bulgaria 27
BE - Belgio 24
JO - Giordania 24
NG - Nigeria 24
ID - Indonesia 23
AR - Argentina 22
TH - Thailandia 22
MX - Messico 20
PL - Polonia 20
IR - Iran 19
TR - Turchia 18
AT - Austria 15
BD - Bangladesh 15
PH - Filippine 15
TW - Taiwan 14
IQ - Iraq 12
SA - Arabia Saudita 12
LT - Lituania 9
SC - Seychelles 9
EC - Ecuador 8
ES - Italia 8
GR - Grecia 8
AU - Australia 7
CL - Cile 7
CO - Colombia 6
HR - Croazia 6
PK - Pakistan 6
LB - Libano 5
PY - Paraguay 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
RO - Romania 4
GH - Ghana 3
HU - Ungheria 3
KE - Kenya 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
MA - Marocco 2
NP - Nepal 2
PT - Portogallo 2
SI - Slovenia 2
UG - Uganda 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
MG - Madagascar 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
Totale 10.348
Città #
Singapore 661
Southend 501
Ashburn 432
Fairfield 341
Chandler 278
San Jose 200
Hanoi 198
Hong Kong 182
Ho Chi Minh City 179
Wilmington 176
Houston 175
Woodbridge 173
Dong Ket 154
Seattle 153
Beijing 144
Hefei 138
Princeton 135
Ann Arbor 131
Cambridge 130
Dublin 99
Bologna 94
Santa Clara 93
Boardman 82
New York 74
Nanjing 69
Abidjan 63
Lauterbourg 60
Los Angeles 57
Westminster 53
Padova 51
Bern 50
Lomé 49
Tokyo 48
Helsinki 46
Seoul 46
Milan 43
Dallas 41
London 41
Jacksonville 39
Buffalo 37
Haiphong 36
Bremen 35
Hyderabad 35
Da Nang 33
Berlin 31
Jinan 31
Nanchang 29
Saint Petersburg 29
Shenyang 29
Frankfurt am Main 27
Sofia 26
Tianjin 25
Abeokuta 24
Brussels 24
Amman 23
Hebei 23
Guangzhou 22
São Paulo 22
Council Bluffs 20
Jiaxing 19
Shanghai 19
Hangzhou 18
Medford 18
Toronto 18
Falls Church 17
Munich 17
Mülheim 17
Redondo Beach 17
San Diego 17
Changsha 15
Chennai 15
Zhengzhou 15
Bengaluru 14
Taizhou 14
Johannesburg 13
Montreal 13
Can Tho 12
Ningbo 12
Warsaw 12
Rome 11
San Venanzo 11
Turin 11
Yubileyny 11
Amsterdam 10
Chicago 10
Haikou 10
Jakarta 10
Orem 10
Phoenix 10
Redmond 10
Indianapolis 9
Redwood City 9
Fuzhou 8
Modena 8
Nuremberg 8
Taiyuan 8
Turku 8
Biên Hòa 7
Ninh Bình 7
Olalla 7
Totale 6.745
Nome #
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 278
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 265
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 256
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 248
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 240
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 232
IFI16 expression is related to selected transcription factors during B-cell differentiation 227
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 226
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 217
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 207
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 203
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 197
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 196
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 194
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 189
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 188
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 180
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 179
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 179
BCL10 down-regulation in peripheral T-cell lymphomas. 178
Pathobiology of hodgkin lymphoma. 177
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 174
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 172
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 170
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 168
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 166
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 166
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 162
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 159
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 153
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 152
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 150
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 144
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. 143
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. 142
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 141
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 141
Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact 138
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 135
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection 131
Gene expression profiling of peripheral T-cell lymphoma: From bench to bedside 131
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. 131
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 130
Intracellular TCR-signaling Pathway: Novel Markers for Lymphoma Diagnosis and Potential Therapeutic Targets 129
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified 129
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 128
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 128
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model 126
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 126
P27 regulation in peripheral T-cell lymphoma not otherwise specified 125
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. 124
Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210 123
TOX Expression in Mycosis Fungoides and Sezary Syndrome 122
Tissue micro-array in haematopathology:present usage and potential. 117
Peripheral T-cell lymphoma. A still uncurable disease? 117
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive 109
Detection of LMO2 in Normal Human Tissue and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody. 107
PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. 103
Proliferation centres in chronic lymphocytic leucemia: correlation with cytogenetic and clinicobiological features in 183 patients analyzed on tissue-microarrays. 102
Expression of classical NF-kappa B pathway molecules in peripheral t-cell lymphoma not otherwise specified. 102
Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence 98
Three-dimensional models: a novel approach for lymphoma research 95
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation 93
LMO2 is a useful marker for the study and diagnosis of haematolymphoid neoplasms. 92
Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes 90
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial 74
null 68
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease 62
Correction to: Three-dimensional models: a novel approach for lymphoma research 61
Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort Study 29
Primary Diffuse Large B-cell Lymphoma of the Central Nervous System: Unmet Medical Need 28
Immunohistochemical Characterization of Tumor Microenvironment Analysis in Glioblastoma IDH-Wildtype 19
Totale 10.581
Categoria #
all - tutte 27.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 0 0 0 0 26 34 288
2021/20221.137 106 65 62 68 103 56 21 62 35 143 237 179
2022/20231.313 161 181 72 153 104 96 31 64 233 27 105 86
2023/2024427 21 67 39 35 35 99 26 25 17 40 12 11
2024/20251.452 102 176 158 104 178 64 114 54 37 96 87 282
2025/20263.449 351 296 311 320 440 207 376 116 770 262 0 0
Totale 10.581